GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Holdings Corp (XKRX:096760) » Definitions » Cyclically Adjusted PS Ratio

JW Holdings (XKRX:096760) Cyclically Adjusted PS Ratio : 0.30 (As of Jun. 05, 2025)


View and export this data going back to 2007. Start your Free Trial

What is JW Holdings Cyclically Adjusted PS Ratio?

As of today (2025-06-05), JW Holdings's current share price is ₩3715.00. JW Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₩12,205.75. JW Holdings's Cyclically Adjusted PS Ratio for today is 0.30.

The historical rank and industry rank for JW Holdings's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:096760' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.09   Med: 0.17   Max: 0.31
Current: 0.29

During the past years, JW Holdings's highest Cyclically Adjusted PS Ratio was 0.31. The lowest was 0.09. And the median was 0.17.

XKRX:096760's Cyclically Adjusted PS Ratio is ranked better than
91.46% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.155 vs XKRX:096760: 0.29

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

JW Holdings's adjusted revenue per share data for the three months ended in Mar. 2025 was ₩3,403.280. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩12,205.75 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


JW Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for JW Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Holdings Cyclically Adjusted PS Ratio Chart

JW Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.11 0.09 0.11 0.25

JW Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.10 0.26 0.25 0.24

Competitive Comparison of JW Holdings's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, JW Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JW Holdings's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JW Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where JW Holdings's Cyclically Adjusted PS Ratio falls into.


;
;

JW Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

JW Holdings's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3715.00/12205.75
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, JW Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3403.28/122.5900*122.5900
=3,403.280

Current CPI (Mar. 2025) = 122.5900.

JW Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 2,216.862 100.051 2,716.274
201509 2,394.799 100.111 2,932.535
201512 2,303.591 100.220 2,817.762
201603 2,504.853 100.561 3,053.572
201606 2,550.639 100.791 3,102.298
201609 2,480.038 101.461 2,996.494
201612 2,353.211 101.561 2,840.453
201703 2,520.707 102.851 3,004.489
201706 2,339.925 102.611 2,795.515
201709 2,423.417 103.491 2,870.666
201712 1,983.148 102.991 2,360.542
201803 2,494.426 104.101 2,937.458
201806 2,433.869 104.130 2,865.333
201809 2,658.505 105.651 3,084.757
201812 2,644.510 104.351 3,106.740
201903 2,404.857 104.491 2,821.408
201906 2,438.909 104.881 2,850.718
201909 2,532.767 105.200 2,951.436
201912 2,567.887 105.121 2,994.610
202003 2,425.453 105.354 2,822.254
202006 2,535.662 105.112 2,957.297
202009 2,565.992 106.198 2,962.072
202012 2,751.175 105.765 3,188.817
202103 2,552.573 107.357 2,914.755
202106 2,650.166 107.579 3,019.967
202109 2,427.883 108.759 2,736.634
202112 3,551.646 109.676 3,969.827
202203 2,787.589 111.848 3,055.312
202206 2,769.725 114.072 2,976.538
202209 3,000.776 114.715 3,206.766
202212 3,310.973 115.179 3,524.006
202303 2,966.785 116.507 3,121.674
202306 3,276.478 117.182 3,427.686
202309 2,977.035 118.964 3,067.785
202312 3,787.009 118.837 3,906.604
202403 3,196.649 120.123 3,262.294
202406 2,972.823 120.007 3,036.802
202409 3,151.021 120.861 3,196.093
202412 3,160.029 121.135 3,197.980
202503 3,403.280 122.590 3,403.280

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


JW Holdings  (XKRX:096760) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


JW Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of JW Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


JW Holdings Business Description

Traded in Other Exchanges
N/A
Address
698 Sindaebang 1-dong, Dongjak-gu, Seoul, KOR, 156-010
JW Holdings Corp is a healthcare solutions provider. It is a drug manufacturer based in Korea and its key focus areas are raw material, completion medicine, medical supplies and medical appliances. The company's array of products comprises of antimicrobials, antifungals, anticancer and gastrointestinal agents. It licenses and markets in its home country and in regions such as United States, Japan, Germany, and China.

JW Holdings Headlines

No Headlines